Clinical Innovation in Rheumatology
portes grátis
Clinical Innovation in Rheumatology
Past, Present, and Future
Liebowitz, Jason; Seo, Philip
Taylor & Francis Ltd
10/2022
184
Dura
Inglês
9781032074924
15 a 20 dias
530
Descrição não disponível.
Chapter 1: Rheumatoid Arthritis
Chapter 2: Axial Spondyloarthritis
Chapter 3: Psoriatic arthritis
Chapter 4: Crystalline Arthritis
Chapter 5: Osteoarthritis
Chapter 6: Systemic Lupus Erythematosus
Chapter 7: Sjogren's Disease
Chapter 8: Scleroderma
Chapter 9: Myositis
Chapter 10: Vasculitis
Chapter 11: Osteoporosis
Chapter 12: Immune-related Adverse Events: A Novel Paradigm of the Immune System
Chapter 13: Complementary and Alternative Medicine Use in Rheumatic Disease
Chapter 14: COVID-19 and MIS-C
Chapter 2: Axial Spondyloarthritis
Chapter 3: Psoriatic arthritis
Chapter 4: Crystalline Arthritis
Chapter 5: Osteoarthritis
Chapter 6: Systemic Lupus Erythematosus
Chapter 7: Sjogren's Disease
Chapter 8: Scleroderma
Chapter 9: Myositis
Chapter 10: Vasculitis
Chapter 11: Osteoporosis
Chapter 12: Immune-related Adverse Events: A Novel Paradigm of the Immune System
Chapter 13: Complementary and Alternative Medicine Use in Rheumatic Disease
Chapter 14: COVID-19 and MIS-C
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Vasculitis;Arthritis;Connective tissue diseases;Genetics;Crystal arthritis;TNFi;Technology;Single Cell RNA Sequencing;Progressive Disease;RA Disease Activity;TNF Inhibitor;Positive HLA B27;Jak Inhibitor;NLRP3 Inflammasome;Cam Modality;BCP Crystal;Connective Tissue Disease ILD;SSc Pah Patient;Systemic Autoimmune Rheumatic Diseases;Gout Flares;Modified Rodnan Skin Score;Coatomer Protein Complex Subunit Alpha;AxSpA;Diffuse SSc;RA Risk;RA Management;DMARD Therapy;Sle Patient;SSc Patient;Diffuse Cutaneous SSc;Knee OA
Chapter 1: Rheumatoid Arthritis
Chapter 2: Axial Spondyloarthritis
Chapter 3: Psoriatic arthritis
Chapter 4: Crystalline Arthritis
Chapter 5: Osteoarthritis
Chapter 6: Systemic Lupus Erythematosus
Chapter 7: Sjogren's Disease
Chapter 8: Scleroderma
Chapter 9: Myositis
Chapter 10: Vasculitis
Chapter 11: Osteoporosis
Chapter 12: Immune-related Adverse Events: A Novel Paradigm of the Immune System
Chapter 13: Complementary and Alternative Medicine Use in Rheumatic Disease
Chapter 14: COVID-19 and MIS-C
Chapter 2: Axial Spondyloarthritis
Chapter 3: Psoriatic arthritis
Chapter 4: Crystalline Arthritis
Chapter 5: Osteoarthritis
Chapter 6: Systemic Lupus Erythematosus
Chapter 7: Sjogren's Disease
Chapter 8: Scleroderma
Chapter 9: Myositis
Chapter 10: Vasculitis
Chapter 11: Osteoporosis
Chapter 12: Immune-related Adverse Events: A Novel Paradigm of the Immune System
Chapter 13: Complementary and Alternative Medicine Use in Rheumatic Disease
Chapter 14: COVID-19 and MIS-C
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Vasculitis;Arthritis;Connective tissue diseases;Genetics;Crystal arthritis;TNFi;Technology;Single Cell RNA Sequencing;Progressive Disease;RA Disease Activity;TNF Inhibitor;Positive HLA B27;Jak Inhibitor;NLRP3 Inflammasome;Cam Modality;BCP Crystal;Connective Tissue Disease ILD;SSc Pah Patient;Systemic Autoimmune Rheumatic Diseases;Gout Flares;Modified Rodnan Skin Score;Coatomer Protein Complex Subunit Alpha;AxSpA;Diffuse SSc;RA Risk;RA Management;DMARD Therapy;Sle Patient;SSc Patient;Diffuse Cutaneous SSc;Knee OA
